Study of the Hematopoietic Niche and the Role of Inflammation in the Pathophysiology of Cytopenias After CAR-T Cell Therapy: Potential of Therapies Directed to Repair the Bone Marrow Microenvironment

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions

Diffuse Large B Cell Lymphoma

Interventions

BIOLOGICAL

CAR-T cell therapy

Patients with diffuse large B-cell lymphoma undergoing consecutive commercial CAR-T therapy at the University Hospital of Salamanca

Trial Locations (1)

RECRUITING

Complejo Asistencial Universitario de Salamanca, Salamanca

All Listed Sponsors

collaborator

Carlos III Health Institute

OTHER_GOV

lead

Instituto de Investigación Biomédica de Salamanca

OTHER